CHARLES M. BAUM - 22 Jun 2023 Form 3 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Director
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Issuer symbol
ACRV
Transactions as of
22 Jun 2023
Transactions value $
$0
Form type
3
Filing time
28 Jun 2023, 16:58:32 UTC
Previous filing
16 Jun 2023
Next filing
10 Aug 2023

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney